MPAL — Medpal AI Income Statement
0.000.00%
Last trade - 00:00- £35.63m
- £35.52m
Annual income statement for Medpal AI, fiscal year end - August 31st, GBP millions except per share, conversion factor applied.
2022 August 31st | 2023 August 31st | 2024 August 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Total Revenue | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||
| Unusual Expense / Income | |||
| Total Operating Expenses | 0.056 | 0.014 | 0.014 |
| Operating Profit | -0.056 | -0.014 | -0.014 |
| Net Income Before Taxes | -0.056 | -0.014 | -0.014 |
| Provision for Income Taxes | |||
| Net Income After Taxes | -0.056 | -0.014 | -0.014 |
| Net Income Before Extraordinary Items | |||
| Net Income | -0.056 | -0.014 | -0.014 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||
| Income Available to Common Shareholders Including Extraordinary Items | |||
| Diluted Net Income | -0.056 | -0.014 | -0.014 |
| Diluted Weighted Average Shares | |||
| Basic EPS Including Extraordinary Items | |||
| Diluted EPS Including Extraordinary Items | |||
| Diluted EPS Excluding Extraordinary Items | |||
| Normalised Income Before Taxes | |||
| Normalised Income After Taxes | |||
| Normalised Income Available to Common Shareholders | |||
| Diluted Normalised EPS | -0 | -0 | -0 |